In the cohorts we adjusted for age, sex, marital status, education, physical and psychiatric comorbidity registered within 10 years before the index date
Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]
GLP-1 medications can cause side effects, especially in the early weeks
Navigating the Consultation: Your Fertility Roadmap If youre considering GLP-1s as part of your fertility journey, working with a multidisciplinary teaman endocrinologist, OB-GYN, and registered dietitiancan be invaluable
While reducing body mass index (BMI) does reduce the risk of cancer incidence, it is not to the extent that lowering BMI reduces mortality risk